Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

WellCare To Resume Medicare Marketing and Sales

TAMPA, Fla. - 
      WellCare Health Plans, Inc. (NYSE: WCG) today announced that the Centers 
      for Medicare & Medicaid Services (“CMS”) released the Company from the 
      previously disclosed sanctions, except as noted below. The Company will 
      resume marketing its Medicare Prescription Dru
Posted : Wed, 04 Nov 2009 11:31:54 GMT
Author : WellCare Health Plans, Inc.
Category : Press Release
News Alerts by Email ( click here )
Press Release News | Home
TAMPA, Fla. - (Business Wire) WellCare Health Plans, Inc. (NYSE: WCG) today announced that the Centers for Medicare & Medicaid Services (“CMS”) released the Company from the previously disclosed sanctions, except as noted below. The Company will resume marketing its Medicare Prescription Drug Plans and Medicare Advantage coordinated care plans over the coming days. The enrollments will be effective beginning January 1, 2010. The Company intends to reinitiate marketing over the next several months in a measured fashion and has been notified by CMS that it will be subject to heightened regulatory monitoring during the upcoming open enrollment periods.

“We are pleased that CMS has recognized the significant improvements we have made across the Company,” said Heath Schiesser, WellCare’s president and chief executive officer. “Providing Medicare beneficiaries access to quality health care and ensuring the satisfaction of the members, providers and government clients we serve are top priorities for WellCare.”

As previously disclosed, the Company is not renewing its contracts with CMS for Medicare Advantage private fee-for-service plans in 2010. In addition, the Company is also not renewing its Medicare Advantage preferred provider organization contract in Ohio in 2010. The sanctions on marketing and enrollment for these plans will not be lifted prior to their planned termination at the conclusion of 2009.

About WellCare Health Plans, Inc.

WellCare Health Plans, Inc. provides managed care services exclusively for government-sponsored health care programs, focusing on Medicaid and Medicare. Headquartered in Tampa, Florida, WellCare offers a variety of health plans for families, children, and the aged, blind, and disabled, as well as prescription drug plans. The Company served approximately 2.3 million members nationwide as of September 30, 2009. For more information about WellCare, please visit the Company’s website at www.wellcare.com.

Cautionary Statement Regarding Forward-Looking Statements

This news release contains “forward-looking” statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions are forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause WellCare’s actual future results to differ materially from those projected or contemplated in the forward-looking statements. These risks and uncertainties include, but are not limited to, WellCare’s current projected financial outlook for 2009, progress toward key initiatives such as increased reliability of the Company’s data and reporting and the management of costs and compliance with the requirements of CMS.

Additional information concerning these and other important risks and uncertainties can be found under the captions “Cautionary Statement Regarding Forward-Looking Statements” and “Risk Factors” in the Company’s 2008 Annual Report on Form 10-K, as amended, and other filings made with the U.S. Securities and Exchange Commission, which contain discussions of WellCare’s business and the various factors that may affect it. WellCare undertakes no duty to update these forward-looking statements to reflect any future events, developments, or otherwise.

WellCare Health Plans, Inc.
Investor Relations:
Gregg Haddad, 813-865-1284
gregg.haddad@wellcare.com
or
Media Relations:
Amy Knapp, 813-290-6208
amy.knapp@wellcare.com


Copyright © 2008 Business Wire. All rights reserved.
Share/Save/Bookmark

Article : WellCare To Resume Medicare Marketing and Sales
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

Ebix Announces its Focus on Singapore & India as Centers of Technology Excellence
ATLANTA - Ebix, Inc. (NASDAQ: EBIX) a leading international supplier of On-Demand software and E-commerce services to the insurance industry, today announced that it has decided to further strengthen its operations in Singapore & India, towards centralizing the company’s worldwide

Jack Morton Uses Augmented Reality To Launch Statoil's New Vision
LONDON, Nov. 23 /PRNewswire/ -- Jack Morton Worldwide, the experiential marketing agency, was appointed to create and produce a global internal event designed to launch Statoil's new vision and visual identity. 30,000 Statoil employees and stakeholders at over 120 locations ...

Monarch Investments Holdings, LLC Announces Midstream Investment Partnership with Metalmark Capital
NEW YORK - Monarch Investments Holdings, LLC (“Monarch”), a private midstream investment partnership formed by industry veterans Greg Sales, Terry Klare, Dave Kenyon and Keith Finger announced today that they have entered into a partnership agreement with Metalmark Capital

Former Ausra Co-Founder Joins GlassPoint Solar
SAN FRANCISCO - GlassPoint Solar, a provider of solar industrial process heat systems, today announced the addition of John O’Donnell, formerly co-founder and EVP of Ausra, as Vice President of Business Development. Mr. O’Donnell joins GlassPoint following the company’s tra

Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conference
SAN DIEGO - Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced positive interim results from a randomized Phase 2 clinical trial evaluating the vascular disrupting agent (VDA) plinabulin (NPI-2358) in combination with standard chem

Research and Markets: Define Where to Streamline: Making Marketing Supply Chains More Efficient, Agile and Enviro-Friendly
DUBLIN - Research and Markets (

Force Protection Appoints Director of Training
LADSON, S.C. - Force Protection, Inc. (NASDAQ: FRPT) today announced that it has named David Ray Hudson as Director of Training at its Training and Capabilities Center located in Roxboro, North Carolina. Prior to joining Force Protection, Mr. Hudson served as the Senior Enlisted Leader for

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.